ATIR HOLDING S A has a total of 34 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BEIJING INNOCARE PHARMA TECH CO LTD, Atrin Pharmaceuticals LLC and CELGENE INT II SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 5 | |
#5 | Hong Kong | 4 | |
#6 | Israel | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Kogan Vladimir | 23 |
#2 | Tabachnik Lev | 9 |
#3 | Tworowski Dmitry | 9 |
#4 | Matsievitch Ron | 9 |
#5 | Tsipe Karina | 8 |
#6 | Lurya Leonid | 8 |
#7 | Munblit Izabella | 8 |
#8 | Karina Tsipe | 3 |
#9 | Izabella Munblit | 3 |
#10 | Leonid Lurya | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018167689A1 | Topical formulation for the treatment of pigmented skin | |
US2020085826A1 | Use of heterocyclic compounds in the treatment of pigmented skin | |
CA2832822A1 | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | |
EP2435414A1 | Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use | |
WO2008117269A2 | Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof | |
CA2914168A1 | Pyrido[1,2-a]pyrimidin-4-one derivatives and their use in the treatment of sexual disorders |